In patients with both type 2 diabetes and an elevated cardiovascular risk, metformin lowers the risk of all-cause mortality but does little to protect against CV death, MI or ischemic stroke, a new evaluation of the SAVOR-TIMI 53 trial has found.
The American Society of Radiologic Technologists (ASRT) has issued a statement in support of new legislation that would change the way key radiopharmaceuticals are bundled by CMS and simplify Medicare billing policies.
The drug industry is not happy about a new plan from the Trump administration that would allow cheaper drugs to be imported from Canada. The initiative, called the Safe Importation Action Plan, was announced by HHS July 31.
An editorial published in The Lancet August 2 scrutinized JUUL Labs’ participation in and sponsorship of e-cigarette research in the U.S., finding the vaping giant fell short in seven of eight categories designed to test ethical integrity.
The FDA has published a new guidance document focused on making improvements to the overall safety of MR environments and MRI-related medical device labeling.
NIH funding opportunities remain numerous for innovators who apply evidence-based medical science to their proposals for smartphone apps, and the agency isn’t hesitant to get behind AI-based approaches.
Average Medicare Part D premiums have dropped for the third year in a row, according to CMS, and they are projected to decline again in 2020. Medicare Part D plans offer prescription drug coverage to Medicare beneficiaries.
The FDA has granted B. Braun Interventional Systems Inc. breakthrough device designation for its SeQuent Please ReX drug-coated PTCA balloon catheter, the company announced August 1.
Deep learning may be able to help specialists differentiate pancreatic diseases on MR images, according to new findings published in Diagnostic and Interventional Imaging.
